ULTRAGENYX Trademark

Trademark Overview

On Wednesday, December 21, 2022, a trademark application was filed for ULTRAGENYX with the United States Patent and Trademark Office. The USPTO has given the ULTRAGENYX trademark a serial number of 97726798. The federal status of this trademark filing is REGISTERED as of Tuesday, February 10, 2026. This trademark is owned by Ultragenyx Pharmaceutical Inc.. The ULTRAGENYX trademark is filed in the Personal, Legal & Social Services category with the following description:

Licensing of intellectual property; online social networking services in the field of rare diseases and disorders
ultragenyx

General Information

Serial Number97726798
Word MarkULTRAGENYX
Filing DateWednesday, December 21, 2022
Status700 - REGISTERED
Status DateTuesday, February 10, 2026
Registration Number8137748
Registration DateTuesday, February 10, 2026
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 12, 2023

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the word "ultragenyx" in a lower-case stylized font.
Pseudo MarkULTRA GENE
Goods and ServicesLicensing of intellectual property; online social networking services in the field of rare diseases and disorders

Classification Information

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 18, 2023
Primary Code045
First Use Anywhere DateTuesday, October 21, 2025
First Use In Commerce DateTuesday, October 21, 2025

Trademark Owner History

Party NameUltragenyx Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameUltragenyx Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameUltragenyx Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Saturday, December 24, 2022NEW APPLICATION ENTERED
Wednesday, January 18, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 21, 2023ASSIGNED TO EXAMINER
Monday, September 25, 2023NON-FINAL ACTION WRITTEN
Monday, September 25, 2023NON-FINAL ACTION E-MAILED
Monday, September 25, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 6, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2023PUBLISHED FOR OPPOSITION
Tuesday, December 12, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 2, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 2, 2024SOU EXTENSION 1 FILED
Friday, August 2, 2024SOU EXTENSION 1 GRANTED
Friday, August 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 2, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 2, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 2, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 2, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, January 16, 2025SOU TEAS EXTENSION RECEIVED
Thursday, January 16, 2025TEAS REQUEST TO DIVIDE RECEIVED
Thursday, July 24, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 16, 2025SOU EXTENSION 2 FILED
Tuesday, July 29, 2025SOU EXTENSION 2 GRANTED
Thursday, January 16, 2025DIVISIONAL REQUEST RECEIVED
Tuesday, July 29, 2025DIVISIONAL PROCESSING COMPLETE
Tuesday, July 29, 2025CORRECTED NOA E-MAILED
Wednesday, July 30, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 30, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, July 30, 2025SOU EXTENSION 3 FILED
Thursday, November 27, 2025SOU EXTENSION 3 GRANTED
Thursday, November 27, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 7, 2026SOU TEAS EXTENSION RECEIVED
Wednesday, January 7, 2026TEAS STATEMENT OF USE RECEIVED
Wednesday, January 7, 2026SOU EXTENSION 4 FILED
Saturday, January 17, 2026SOU EXTENSION 4 GRANTED
Wednesday, January 7, 2026USE AMENDMENT FILED
Saturday, January 17, 2026STATEMENT OF USE PROCESSING COMPLETE
Sunday, January 18, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 20, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 20, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 10, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, February 10, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

ultragenyx field rare diseases disorders services networking intellectual property online social